Receptor clustering and transmembrane signaling in T cells

Trends in Biochemical Sciences

Volumn 26, Issue 5, 2001, Pages 304-310

  Cochran, Jennifer R ^a   Aivazian, Dikran ^a   Cameron, Thomas O ^a   Stern, Lawrence J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL SURFACE RECEPTOR; OLIGOMER; PEPTIDE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CELL ACTIVATION; CELL SURFACE; IMMUNE SYSTEM; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MEMBRANE; ENZYME ACTIVATION; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 2042538051     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(01)01815-1     Document Type: Review

References (49)

1. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:1997;346-354.
2. Hubbard S.R., Till J.H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69:2000;373-398.
3. Falke J.J., et al. The two-component signaling pathway of bacterial chemotaxis: amolecular view of signal transduction by receptors, kinases, and adaptation enzymes. Annu. Rev. Cell Dev. Biol. 13:1997;457-512.
4. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:1994;287-299.
5. Hennecke J., Wiley D.C. T cell receptor-MHC interactions up close. Cell. 104:2001;1-4.
6. Davis M.M., et al. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16:1998;523-544.
7. Qian D., Weiss A. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9:1997;205-212.
8. Dustin M.L., Chan A.C. Signaling takes shape in the immune system. Cell. 103:2000;283-294.
9. Yoon S.T., et al. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity. 1:1994;563-569.
10. Irving B.A., Weiss A. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 64:1991;891-901.
11. Letourneur F., Klausner R.D. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor ζ family proteins. Proc. Natl. Acad. Sci. USA. 88:1991;8905-8909.
12. Spencer D.M., et al. Controlling signal transduction with synthetic ligands. Science. 262:1993;1019-1024.
13. Lanzavecchia A., et al. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell. 96:1999;1-4.
14. Sloan-Lancaster J., Allen P.M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1996;1-27.
15. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. Med. 187:1998;1367-1371.
16. Howard M.C., et al. MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes. Immunol. Today. 20:1999;161-165.
17. Abastado J.P., et al. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J.Exp. Med. 182:1995;439-447.
18. Hamad A.R., et al. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. J. Exp. Med. 188:1998;1633-1640.
19. Appel H., et al. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells. J.Biol. Chem. 275:2000;312-321.
20. Casares S., et al. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation. J.Exp. Med. 190:1999;543-553.
21. Boniface J.J., et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity. 9:1998;459-466.
22. Delon J., et al. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity. 9:1998;467-473.
23. Cochran J.R., Stern L.J. A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. Chem. Biol. 7:2000;683-696.
24. Cochran J.R., et al. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity. 12:2000;241-250.
25. Ding Y.H., et al. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity. 11:1999;45-56.
26. + T cells by HLA-DR1 oligomers is dependent on an active cellular process. J. Immunol. 166:2001;741-745.
27. Janeway C.A. Jr. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today. 16:1995;223-225.
28. Livnah O., et al. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat. Struct. Biol. 5:1998;993-1004.
29. Alam S.M., et al. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity. 10:1999;227-237.
30. Bachmann M.F., Ohashi P.S. The role of T-cell receptor dimerization in T-cell activation. Immunol. Today. 20:1999;568-756.
31. Fernandez-Miguel G., et al. Multivalent structure of an αβ T cell receptor. Proc. Natl. Acad. Sci. USA. 96:1999;1547-1552.
32. Monks C.R., et al. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
33. Grakoui A., et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
34. Germain R.N. T-cell signaling: the importance of receptor clustering. Curr. Biol. 7:1997;R640-R644.
35. Anderson H.A., et al. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:2000;156-162.
36. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:2000;17221-17224.
37. Turley S.J., et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527.
38. Viola A., et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
39. Wulfing C., Davis M.M. Areceptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1998;2266-2269.
40. Viola A., Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science. 273:1996;104-106.
41. van der Merwe P.A., et al. Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition. Semin. Immunol. 12:2000;5-21.
42. Sykulev Y., et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity. 4:1996;565-571.
43. Reay P.A., et al. Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies. J. Immunol. 164:2000;5626-5634.
44. Krummel M.F., et al. Differential clustering of CD4 and CD3ζ during T cell recognition. Science. 289:2000;1349-1352.
45. Langlet C., et al. Membrane rafts and signaling by the multichain immune recognition receptors. Curr. Opin. Immunol. 12:2000;250-255.
46. van Oers N.S., et al. ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR ζ in murine thymocytes and lymph node T cells. Immunity. 1:1994;675-685.
47. Shaw A.S., Dustin M.L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity. 6:1997;361-369.
48. Aivazian D.A., Stern L.J. T cell receptor ζ phosphorylation is regulated by a lipid-dependent folding transition. Nat. Struct. Biol. 7:2000;1023-1026.
49. Dustin M.J., Cooper J.A. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1:2000;23-28.